D
Davinder S. Jassal
Researcher at University of Manitoba
Publications - 246
Citations - 7003
Davinder S. Jassal is an academic researcher from University of Manitoba. The author has contributed to research in topics: Cardiac magnetic resonance imaging & Cardiotoxicity. The author has an hindex of 39, co-authored 234 publications receiving 6133 citations. Previous affiliations of Davinder S. Jassal include Dalhousie University & Harvard University.
Papers
More filters
Journal ArticleDOI
Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon
Tomas G. Neilan,James L. Januzzi,Elizabeth Lee-Lewandrowski,Thanh Thao Ton-Nu,Danita M. Yoerger,Davinder S. Jassal,Kent B. Lewandrowski,Arthur J. Siegel,Jane E. Marshall,Pamela S. Douglas,David Lawlor,Michael H. Picard,Malissa J. Wood +12 more
TL;DR: Completion of a marathon is associated with correlative biochemical and echocardiographic evidence of cardiac dysfunction and injury, and this risk is increased in those participants with less training.
Journal ArticleDOI
The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
Nazanin Fallah-Rad,Jonathan R. Walker,Anthony W. Wassef,Matthew Lytwyn,Sheena Bohonis,Tielan Fang,Ganhong Tian,Iain D.C. Kirkpatrick,Pawan K. Singal,Marianne Krahn,Debjani Grenier,Davinder S. Jassal +11 more
TL;DR: Both TVI and strain imaging were able to detect pre-clinical changes in LV systolic function, before conventional changes in left ventricular ejection fraction (LVEF) in patients receiving trastuzumab in the adjuvant setting.
Journal ArticleDOI
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin,John R. Mackey,Sheri L. Koshman,Davinder S. Jassal,Marshall Pitz,Mark J. Haykowsky,Joseph J Pagano,Kelvin Chow,Richard B. Thompson,Larissa J. Vos,Sunita Ghosh,Gavin Y. Oudit,Justin A. Ezekowitz,D. Ian Paterson +13 more
TL;DR: Perindopril and bisoprolol were well tolerated in patients with HER2-positive early breast cancer who received trastuzumab and protected against cancer therapy-related declines in LVEF; however, trastzumab-mediated left ventricular remodeling-the primary outcome-was not prevented by these pharmacotherapies.
Journal ArticleDOI
Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance Imaging
Jonathan R. Walker,Navdeep Bhullar,Nazanin Fallah-Rad,Matthew Lytwyn,Mehrdad Golian,Tielan Fang,Arthur R. Summers,Pawan K. Singal,Ivan Barac,Iain D.C. Kirkpatrick,Davinder S. Jassal +10 more
TL;DR: As compared with conventional MUGA, RT3D TTE is a feasible, accurate, and reproducible alternate imaging modality for the serial monitoring of LVEF in patients with breast cancer.
Journal ArticleDOI
Relation of biomarkers and cardiac magnetic resonance imaging after marathon running.
Negareh Mousavi,Andrew Czarnecki,Kanwal Kumar,Nazanin Fallah-Rad,Matthew Lytwyn,Song-Yee Han,Andrew Francis,Jonathan R. Walker,Iain D.C. Kirkpatrick,Tomas G. Neilan,Sat Sharma,Davinder S. Jassal +11 more
TL;DR: In this paper, the authors demonstrate the cardiac changes associated with participation in a marathon using serial cardiac biomarkers, echocardiography, and cardiac magnetic resonance (CMR) imaging.